Acotiamide (monohydrochloride trihydrate)
CAT:
804-HY-B2155-01
Size:
100 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Acotiamide (monohydrochloride trihydrate)
- CAS Number: 773092-05-0
- UNSPSC Description: Acotiamide monohydrochloride trihydrate is an orally active, selective and reversible acetylcholinesterase (AChE) inhibitor, with IC50 of 1.79 μM. Acotiamide monohydrochloride trihydrate can enhance gastric contractility and accelerate delayed gastric emptying. Acotiamide monohydrochloride trihydrate has the potential for the research of functional dyspepsia involving gastric motility dysfunction and intestinal inflammatory [1][2][3].
- Target Antigen: Cholinesterase (ChE)
- Type: Reference compound
- Related Pathways: Neuronal Signaling
- Applications: Neuroscience-Neuromodulation
- Field of Research: Metabolic Disease; Inflammation/Immunology
- Assay Protocol: https://www.medchemexpress.com/acotiamide-monohydrochloride-trihydrate.html
- Purity: 99.49
- Solubility: DMSO : 125 mg/mL (ultrasonic)|H2O : 3.03 mg/mL (ultrasonic;warming;heat to 60°C)
- Smiles: O=C(C1=CSC(NC(C2=CC(OC)=C(OC)C=C2O)=O)=N1)NCCN(C(C)C)C(C)C.[H]Cl.O.O.O
- Molecular Weight: 541.06
- References & Citations: [1]Hiroshi Yamawaki, et al. Acotiamide attenuates central urocortin 2-induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF-α productions in LPS-stimulated macrophage cell lines. Neurogastroenterol Motil. 2020 Aug;32(8):e13813.|[2]Matsunaga Y, et al. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride. J Pharmacol Exp Ther. 2011 Mar;336(3):791-800. |[3]Kazuyoshi Y oshii, et al. Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach. Pharmaceutical Research, 33(2), 292–300.
- Shipping Conditions: Room Temperature
- Storage Conditions: 4°C (Powder, sealed storage, away from moisture and light)
- Clinical Information: Launched